Previous close | 217.25 |
Open | 217.20 |
Bid | 0.00 x 0 |
Ask | 230.00 x 0 |
Day's range | 214.00 - 217.20 |
52-week range | 174.50 - 274.60 |
Volume | |
Avg. volume | 370,185 |
Market cap | 59.715B |
Beta (5Y monthly) | 0.73 |
PE ratio (TTM) | 27.43 |
EPS (TTM) | 7.92 |
Earnings date | N/A |
Forward dividend & yield | 4.25 (2.23%) |
Ex-dividend date | 27 Apr 2023 |
1y target est | N/A |
European shares edged lower on Monday as rising government bond yields and concerns over the Israel-Hamas war kept investors on edge, while Italy's FTSE MIB index was among top gainers across the regional markets. The pan-European STOXX 600 ended 0.1% lower after declines of over 3% in the previous week. While European Union leaders are set to call for a "humanitarian pause" in the Israel-Hamas war so aid could reach them, Israel continued its bombardment of the besieged enclave.
Getinge announced today that it has acquired 100 percent of the shares in US-based Healthmark Industries Co. Inc., a leading provider of innovative instrument care and infection control consumables, for approximately USD 320 M. This strategic step enhances Getinge's presence within sterile reprocessing in the US and facilitates a global expansion for Healthmark.
Getinge announces today an agreement to acquire 100% of the shares in High Purity New England, Inc. a leading US-based company in the fast-growing areas of custom single-use solutions for bioprocessing applications.